KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Liabilities and Shareholders Equity (2020 - 2025)

Oscar Health (OSCR) has disclosed Liabilities and Shareholders Equity for 6 consecutive years, with $5.7 billion as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Liabilities and Shareholders Equity rose 28.17% year-over-year to $5.7 billion, compared with a TTM value of $18.0 billion through Dec 2025, down 4.13%, and an annual FY2024 reading of $4.8 billion, up 34.4% over the prior year.
  • Liabilities and Shareholders Equity was $5.7 billion for Q3 2025 at Oscar Health, down from $6.4 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $6.4 billion in Q2 2025 and bottomed at $3.2 billion in Q3 2021.
  • Average Liabilities and Shareholders Equity over 5 years is $4.4 billion, with a median of $4.5 billion recorded in 2024.
  • The sharpest move saw Liabilities and Shareholders Equity soared 46.19% in 2021, then fell 22.26% in 2023.
  • Year by year, Liabilities and Shareholders Equity stood at $3.3 billion in 2021, then skyrocketed by 36.28% to $4.5 billion in 2022, then fell by 20.44% to $3.6 billion in 2023, then surged by 34.4% to $4.8 billion in 2024, then increased by 18.7% to $5.7 billion in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for OSCR at $5.7 billion in Q3 2025, $6.4 billion in Q2 2025, and $5.8 billion in Q1 2025.